Of decrements and disorders: Assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures

Environmental Health: A Global Access Science Source

Volumn 14, Issue 1, 2015, Pages

  Sagiv, Sharon K ^a,b   Kalkbrenner, Amy E ^c   Bellinger, David C ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Autism spectrum disorders; Environmental factors; Neurodevelopmental disorders; Prospective studies

Indexed keywords

DESIGN METHOD; DISABILITY; ENVIRONMENTAL FACTOR; ETIOLOGY; INSTRUMENTATION; NEUROLOGY; PHENOTYPE; POLLUTION EXPOSURE; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; RISK FACTOR; TOXIC SUBSTANCE;

ARTICLE; AUTISM; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL TOXICANT EXPOSURE; FEASIBILITY STUDY; HUMAN; INVESTIGATIVE PROCEDURES; LONGITUDINAL STUDY; NERVE CELL DIFFERENTIATION; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE STUDY; QUANTITATIVE TRAIT; RISK FACTOR; ADVERSE EFFECTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DANGEROUS GOODS; FEMALE; INFANT; MALE; NEURODEVELOPMENTAL DISORDERS; NEWBORN; PRESCHOOL CHILD; REPRODUCIBILITY;

DANGEROUS GOODS;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HAZARDOUS SUBSTANCES; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEURODEVELOPMENTAL DISORDERS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 84928750071     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-14-8     Document Type: Article

References (13)

1. Grandjean P, Landrigan PJ: Neurobehavioural effects of developmental toxicity. Lancet Neurol 2014, 13:330-8. 10.1016/S1474-4422(13)70278-3
2. Grandjean P, Landrigan PJ: Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368:2167-78. 10.1016/S0140-6736(06)69665-7
3. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators: Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 2014, 63:1-21.
4. Rodier PM, Ingram JL, Tisdale B, Nelson S, Romano J: Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 1996, 370:247-61. Publisher Full Text 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2
5. Stamou M, Streifel KM, Goines PE, Lein PJ: Neuronal connectivity as a convergent target of gene x environment interactions that confer risk for Autism Spectrum Disorders. Neurotoxicol Teratol 2013, 36:3-16.
6. Durkin MS, Maenner MJ, Meaney FJ, Levy SE, DiGuiseppi C, Nicholas JS, et al.: Socioeconomic inequality in the prevalence of autism spectrum disorder: evidence from a U.S. cross-sectional study. PloS One 2010, 5:e11551. 10.1371/journal.pone.0011551
7. Constantino JN, Todd RD: Autistic traits in the general population: a twin study. Arch Gen Psychiatry 2003, 60:524-30. 10.1001/archpsyc.60.5.524
8. Lord C, Leventhal BL, Cook EH: Quantifying the phenotype in autism spectrum disorders. Am J Med Genet 2001, 105:36-8. 10.1002/1096-8628(20010108)105:1<36::AID-AJMG1053>3.0.CO;2-4
9. Rose G: Sick Individuals and Sick Populations. Int J Epidemiol 1985, 14:32-8. 10.1093/ije/14.1.32
10. London EB: Categorical diagnosis: a fatal flaw for autism research. Trends Neurosci 2014, 37:683-6. 10.1016/j.tins.2014.10.003
11. Morris SE, Cuthbert BN: Research Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin Neurosci 2012, 14:29-37.
12. Maenner MJ, Rice CE, Arneson CL, Cunniff C, Schieve LA, Carpenter LA, et al.: Potential impact of DSM-5 criteria on autism spectrum disorder prevalence estimates. JAMA Psychiatry 2014, 71:292-300. 10.1001/jamapsychiatry.2013.3893
13. Bellinger DC: What is an adverse effect? A possible resolution of clinical and epidemiological perspectives on neurobehavioral toxicity. Environ Res 2004, 95:394-405. 10.1016/j.envres.2003.07.013